118 related articles for article (PubMed ID: 7530200)
1. Influence of a Ca2+ channel agonist, Bay k-8644, on the anticonvulsant activity of NMDA and non-NMDA receptor antagonists.
Czuczwar SJ; Gasior M; Turski WA; Kleinrok Z
Eur J Pharmacol; 1994 Oct; 264(1):103-6. PubMed ID: 7530200
[TBL] [Abstract][Full Text] [Related]
2. Influence of combined treatment with NMDA and non-NMDA receptor antagonists on electroconvulsions in mice.
Czuczwar SJ; Borowicz KK; Kleinrok Z; Tutka P; Zarnowski T; Turski WA
Eur J Pharmacol; 1995 Aug; 281(3):327-33. PubMed ID: 8521917
[TBL] [Abstract][Full Text] [Related]
3. Antagonism of various tonic convulsions in mice by dextrorphan and dizocilpine.
Akaike N; Himori N
Naunyn Schmiedebergs Arch Pharmacol; 1993 Jun; 347(6):652-7. PubMed ID: 7689706
[TBL] [Abstract][Full Text] [Related]
4. Anticonvulsant properties of calcium channel blockers in mice: N-methyl-D-,L-aspartate- and Bay K 8644-induced convulsions are potently blocked by the dihydropyridines.
Palmer GC; Stagnitto ML; Ray RK; Knowles MA; Harvey R; Garske GE
Epilepsia; 1993; 34(2):372-80. PubMed ID: 7681002
[TBL] [Abstract][Full Text] [Related]
5. Influence of BAY k-8644, a calcium channel agonist, on the anticonvulsant activity of conventional anti-epileptics against electroconvulsions in mice.
Gasior M; Kleinrok Z; Czuczwar SJ
Neuropharmacology; 1995 Apr; 34(4):433-8. PubMed ID: 7566475
[TBL] [Abstract][Full Text] [Related]
6. Influence of isradipine, niguldipine and dantrolene on the anticonvulsive action of conventional antiepileptics in mice.
Borowicz KK; Gasior M; Kleinrok Z; Czuczwar SJ
Eur J Pharmacol; 1997 Mar; 323(1):45-51. PubMed ID: 9105875
[TBL] [Abstract][Full Text] [Related]
7. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
[TBL] [Abstract][Full Text] [Related]
8. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil.
Löscher W; Hönack D
Br J Pharmacol; 1994 Dec; 113(4):1349-57. PubMed ID: 7889291
[TBL] [Abstract][Full Text] [Related]
9. Interactions of excitatory amino acid antagonists with conventional antiepileptic drugs.
Czuczwar SJ; Turski WA; Kleinrok Z
Metab Brain Dis; 1996 Jun; 11(2):143-52. PubMed ID: 8776716
[TBL] [Abstract][Full Text] [Related]
10. Low doses of NMDA receptor antagonists synergistically increase the anticonvulsant effect of the AMPA receptor antagonist NBQX in the kindling model of epilepsy.
Löscher W; Rundfeldt C; Hönack D
Eur J Neurosci; 1993 Nov; 5(11):1545-50. PubMed ID: 7904524
[TBL] [Abstract][Full Text] [Related]
11. NMDA-receptor blockers but not NBQX, an AMPA-receptor antagonist, inhibit spreading depression in the rat brain.
Nellgård B; Wieloch T
Acta Physiol Scand; 1992 Dec; 146(4):497-503. PubMed ID: 1283483
[TBL] [Abstract][Full Text] [Related]
12. Anticonvulsant activity of 5,7DCKA, NBQX, and felbamate against some chemoconvulsants in DBA/2 mice.
De Sarro G; Ongini E; Bertorelli R; Aguglia U; De Sarro A
Pharmacol Biochem Behav; 1996 Oct; 55(2):281-7. PubMed ID: 8951966
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of in vivo effects of AMPA and NMDA receptor ligands using drug discrimination methods and convulsant/anticonvulsant activity.
Arnt J; Sánchez C; Lenz SM; Madsen U; Krogsgaard-Larsen P
Eur J Pharmacol; 1995 Oct; 285(3):289-97. PubMed ID: 8575516
[TBL] [Abstract][Full Text] [Related]
14. The AMPA receptor antagonist GYKI 52466 reverses the anti-cataleptic effects of the competitive NMDA receptor antagonist CGP 37849.
Hauber W; Waldenmeier MT
Eur J Pharmacol; 1994 May; 256(3):339-42. PubMed ID: 7913894
[TBL] [Abstract][Full Text] [Related]
15. Effects of dextromethorphan on the seizures induced by kainate and the calcium channel agonist BAY k-8644: comparison with the effects of dextrorphan.
Kim HC; Ko KH; Kim WK; Shin EJ; Kang KS; Shin CY; Jhoo WK
Behav Brain Res; 2001 May; 120(2):169-75. PubMed ID: 11182165
[TBL] [Abstract][Full Text] [Related]
16. Aniracetam reverses the anticonvulsant action of NBQX and GYKI 52466 in DBA/2 mice.
Chapman AG; al-Zubaidy Z; Meldrum BS
Eur J Pharmacol; 1993 Feb; 231(2):301-3. PubMed ID: 8453982
[TBL] [Abstract][Full Text] [Related]
17. The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in mice.
Chapman AG; Smith SE; Meldrum BS
Epilepsy Res; 1991 Jul; 9(2):92-6. PubMed ID: 1794356
[TBL] [Abstract][Full Text] [Related]
18. Effects of some excitatory amino acid antagonists on imipenem-induced seizures in DBA/2 mice.
De Sarro G; Ammendola D; Nava F; De Sarro A
Brain Res; 1995 Feb; 671(1):131-40. PubMed ID: 7728525
[TBL] [Abstract][Full Text] [Related]
19. Effects of antiepileptic drugs, calcium channel blockers and other compounds on seizures induced by activation of voltage-dependent L calcium channel in DBA/2 mice.
De Sarro G; Ascioti C; di Paola ED; Vidal MJ; De Sarro A
Gen Pharmacol; 1992 Nov; 23(6):1205-16. PubMed ID: 1283140
[TBL] [Abstract][Full Text] [Related]
20. The competitive NMDA antagonist, D-CPP-ene, potentiates the anticonvulsant activity of conventional antiepileptics against maximal electroshock-induced seizures in mice.
Zarnowski T; Kleinrok Z; Turski WA; Czuczwar SJ
Neuropharmacology; 1994 May; 33(5):619-24. PubMed ID: 7936096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
